Arkolith/Insider Trading/AQST/Form 4

Kraus Carl N

Chief Medical OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Oct 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$142K
Net Open-Market Flow
-$142K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Sell(S)20K$7.00$142K282K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-015047) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML